SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 23, 2004--BayBio announced today the election of the new Directors to its distinguished Board. This select group joins BayBio in its on-going effort to serve the bioscience industry in Northern California. These new Board Members will join a highly visible industry Board with members who have served for more that a decade.
“We are very pleased to have the commitment of these industry leaders to help set the vision of BayBio,” said Matt Gardner, President. “Applying this collection of international leaders in our industry will continue to generate results for our members and life science companies throughout the region.”
The BayBio Board of Directors plays a key role in identifying the needs of the bioscience community, creating an agenda that addresses these needs, promoting the industry’s science and innovation, and supporting a forum for members to exchange information and ideas.
The new Board Members in 2004-2005 include:
G. Steven Burrill Burrill & Company
Paul Heiden Bayer HealthCare, Division of Bayer AG
Bruce W. Jenett Heller Ehrman White & McAuliffe LLP
Gail Maderis FivePrime Therapeutics, Inc.
Dr. Jennie P. Mather Raven Biotechnologies, Inc.
Jeffrey N. Peterson Target Discovery, Inc.
Glen Y. Sato Protein Design Labs, Inc.
Steve Sawyer Woodruff-Sawyer & Co.
Tom Smart XOMA (US) LLC
Brad Vale, Ph.D. Johnson & Johnson Development Corporation
BayBio is Northern California’s bioscience association. We support the regional bioscience community through networking, advocacy, group purchasing, and communicating the impact of our industry on the community. Our members include organizations engaged in or supportive of research, development, and commercialization of products derived from living organisms. For more information on BayBio, please visit www.baybio.org or call 650-871-7101.
Contacts
BayBio Isela Galvez, 650-871-7101 igalvez@baybio.org
